Comparison Tscan Therapeutics (TCRX) with Competitors
Tscan Therapeutics (TCRX) industry is Biotechnology.
Operating Margin
TCRX-1476.00%
Industry-2055.25%
Upside+579.25%
Debt-to-Equity
TCRX22.51%
Industry28.27%
Upside-20.38%
P/E
TCRX-0.99
Industry-20.52
Upside+1953.11%
P/S
TCRX7.14
Industry10.01
Upside-28.73%
P/B
TCRX0.42
Industry5.15
Upside-91.88%